The microRNA-124-iGluR2/3 pathway regulates glucagon release from alpha cells

Oncotarget

Volumn 7, Issue 17, 2016, Pages 24734-24743

  Zhang, Haiyang ^a   Liu, Rui ^a   Deng, Ting ^a   Wang, Xia ^a   Lang, Hongmei ^b   Qu, Yanjun ^a   Duan, Jingjing ^a   Huang, Dingzhi ^a   Ying, Guoguang ^a   Ba, Yi ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

A cell; Glucagon; iGluR2 3; Metabolism; miR 124

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN; IONOTROPIC RECEPTOR; IONOTROPIC RECEPTOR 2; IONOTROPIC RECEPTOR 3; MESSENGER RNA; MICRORNA 124; UNCLASSIFIED DRUG; AMPA RECEPTOR; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 2; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 3; MICRORNA; MIRN124 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE TARGETING; GENETIC TRANSFECTION; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLUCOTOXICITY; IGLUR2 GENE; IGLUR3 GENE; INSULIN RELEASE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PANCREAS ISLET ALPHA CELL; PREDICTIVE VALUE; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; GENETICS; HUMAN; METABOLISM; RAT; SIGNAL TRANSDUCTION;

3' UNTRANSLATED REGIONS; ANIMALS; BLOOD GLUCOSE; GLUCAGON; GLUCAGON-SECRETING CELLS; HUMANS; MICE; MICE, INBRED C57BL; MICRORNAS; RATS; RECEPTORS, AMPA; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84966565053     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.8270     Document Type: Article

References (38)

1. Pasquinelli AE. NON-CODING RNA MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nature Reviews Genetics. 2012; 13:271-282.
2. Ambros V. The functions of animal microRNAs. Nature. 2004; 431:350-355.
3. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 2004; 116:281-297.
4. Zhou H, Tran PO, Yang S, Zhang T, LeRoy E, Oseid E, Robertson RP. Regulation of alpha-cell function by the beta-cell during hypoglycemia in Wistar rats: the "switchoff" hypothesis. Diabetes. 2004; 53:1482-1487.
5. Unger RH. Glucagon physiology and pathophysiology in the light of new advances. Diabetologia. 1985; 28:574-578.
6. Lang H, Ai Z, You Z, Wan Y, Guo W, Xiao J, Jin X. Characterization of miR-218/322-Stxbp1 pathway in the process of insulin secretion. J Mol Endocrinol. 2015; 54:65-73.
7. Shantikumar S, Caporali A, Emanueli C. Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res. 2012; 93:583-593.
8. Cabrera O, Jacques-Silva MC, Speier S, Yang SN, Kohler M, Fachado A, Vieira E, Zierath JR, Kibbey R, Berman DM, Kenyon NS, Ricordi C, Caicedo A, Berggren PO. Glutamate is a positive autocrine signal for glucagon release. Cell Metabolism. 2008; 7:545-554.
9. Bertrand G, Gross R, Puech R, Loubatieres-Mariani MM, Bockaert J. Glutamate stimulates glucagon secretion via an excitatory amino acid receptor of the AMPA subtype in rat pancreas. Eur J Pharmacol. 1993; 237:45-50.
10. Moriyama Y, Hayashi M. Glutamate-mediated signaling in the islets of Langerhans: a thread entangled. Trends Pharmacol Sci. 2003; 24:511-517.
11. Hayashi M, Otsuka M, Morimoto R, Hirota S, Yatsushiro S, Takeda J, Yamamoto A, Moriyama Y. Differentiationassociated Na+-dependent inorganic phosphate cotransporter (DNPI) is a vesicular glutamate transporter in endocrine glutamatergic systems. J Biol Chem. 2001; 276:43400-43406.
12. Mutel E, Gautier-Stein A, Abdul-Wahed A, Amigo-Correig M, Zitoun C, Stefanutti A, Houberdon I, Tourette JA, Mithieux G, Rajas F. Control of blood glucose in the absence of hepatic glucose production during prolonged fasting in mice: induction of renal and intestinal gluconeogenesis by glucagon. Diabetes. 2011; 60:3121-3131.
13. Longuet C, Sinclair EM, Maida A, Baggio LL, Maziarz M, Charron MJ, Drucker DJ. The Glucagon Receptor Is Required for the Adaptive Metabolic Response to Fasting. Cell Metabolism. 2008; 8:359-371.
14. Yu J. miRNAs in mammalian ureteric bud development. Pediatr Nephrol. 2014; 29:745-749.
15. Liu YT, Hu WC, Wang HF, Lu MH, Shao CX, Menzel C, Yan Z, Li Y, Zhao S, Khaitovich P, Liu MF, Chen W, Barnes BM, Yan J. Genomic analysis of miRNAs in an extreme mammalian hibernator, the Arctic ground squirrel. Physiological Genomics. 2010; 42A:39-51.
16. Uehara S, Muroyama A, Echigo N, Morimoto R, Otsuka M, Yatsushiro S, Moriyama Y. Metabotropic glutamate receptor type 4 is involved in autoinhibitory cascade for glucagon secretion by alpha cells of islet of Langerhans. Cell Structure and Function. 2004; 29:106-106.
17. Zacher T, Knerr I, Rascher W, Kalden JR, Wassmuth R. Characterization of monocyte-derived dendritic cells in recent-onset diabetes mellitus type 1. Clinical Immunology. 2002; 105:17-24.
18. Sakurai M, Higashide T, Takeda H, Shirao Y. Characterization and diabetes-induced impairment of nitric oxide synthase in rat choroid. Current Eye Research. 2002; 24:139-146.
19. Park SH, Park JH, Shim HM, Na AY, Bae KC, Lim JG, Song DK. Protection of pancreatic beta-cells against glucotoxicity by short-term treatment with GLP-1. Biochemical and Biophysical Research Communications. 2015; 459:561-567.
20. Lee JS, Kim YR, Park JM, Kim YE, Baek NI, Hong EK. Cyanidin-3-glucoside isolated from mulberry fruits protects pancreatic beta-cells against glucotoxicityinduced apoptosis. Molecular Medicine Reports. 2015; 11:2723-2728.
21. Shen XX, Li HL, Pan L, Hong J, Xiao J, Hermansen K, Jeppesen PB, Li GW. Glucotoxicity and alpha Cell Dysfunction: Involvement of the PI3K/Akt Pathway in Glucose-Induced Insulin Resistance in Rat Islets and Clonal alpha TC1-6 Cells. Endocrine Research. 2012; 37:12-24.
22. Sun LL, Jiang BG, Li WT, Zou JJ, Shi YQ, Liu ZM. MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Research and Clinical Practice. 2011; 91:94-100.
23. Kim JW, You YH, Jung S, Suh-Kim H, Lee IK, Cho JH, Yoon KH. miRNA-30a-5p-mediated silencing of Beta2/NeuroD expression is an important initial event of glucotoxicity-induced beta cell dysfunction in rodent models. Diabetologia. 2013; 56:847-855.
24. Lynch J, Fay J, Meehan M, Bryan K, Watters KM, Murphy DM, Stallings RL. MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-beta signalling pathway. Carcinogenesis. 2012; 33:976-985.
25. Wang Y, Yu Y, Tsuyada A, Ren X, Wu X, Stubblefield K, Rankin-Gee EK, Wang SE. Transforming growth factorbeta regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene. 2011; 30:1470-1480.
26. Zlotnik A, Gruenbaum BF, Klin Y, Gruenbaum SE, Ohayon S, Sheiner E, Kuts R, Boyko M, Bichovsky Y, Shapira Y, Teichberg VI. The Effects of Insulin, Glucagon, Glutamate, and Glucose Infusion on Blood Glutamate and Plasma Glucose Levels in Naive Rats. Journal of Neurosurgical Anesthesiology. 2011; 23:323-328.
27. Abu Fanne R, Nassar T, Heyman SN, Hijazi N, Higazi AA. Insulin and glucagon share the same mechanism of neuroprotection in diabetic rats: role of glutamate. American Journal of Physiology-Regulatory Integrative and Comparative Physiology. 2011; 301:R668-R673.
28. Easom RA, Zammit VA. Acute effects of starvation and treatment of rats with anti-insulin serum, glucagon and catecholamines on the state of phosphorylation of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase in vivo. Biochem J. 1987; 241:183-188.
29. Hosaka H, Kusano M, Zai H, Kawada A, Kuribayashi S, Shimoyama Y, Nagoshi A, Maeda M, Kawamura O, Mori M. Monosodium glutamate stimulates secretion of glucagon-like peptide-1 and reduces postprandial glucose after a lipid-containing meal. Aliment Pharmacol Ther. 2012; 36:895-903.
30. Wang C, Mao R, Van de Casteele M, Pipeleers D, Ling Z. Glucagon-like peptide-1 stimulates GABA formation by pancreatic beta-cells at the level of glutamate decarboxylase. Am J Physiol Endocrinol Metab. 2007; 292:E1201-1206.
31. Uehara S, Jung SK, Morimoto R, Arioka S, Miyaji T, Juge N, Hiasa M, Shimizu K, Ishimura A, Otsuka M, Yamamoto A, Maechler P, Moriyama Y. Vesicular storage and secretion of L-glutamate from glucagon-like peptide 1-secreting clonal intestinal L cells. J Neurochem. 2006; 96:550-560.
32. Eizirik DL, Korbutt GS, Hellerstrom C. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. J Clin Invest. 1992; 90:1263-1268.
33. Fred RG, Bang-Berthelsen CH, Mandrup-Poulsen T, Grunnet LG, Welsh N. High glucose suppresses human islet insulin biosynthesis by inducing miR-133a leading to decreased polypyrimidine tract binding protein-expression. PLoS One. 2010; 5:e10843.
34. Conget I, Sarri Y, Novials A, Casamitjana R, Vives M, Gomis R. Functional properties of isolated human pancreatic islets beneficial effects of culture and exposure to high glucose concentrations. Diabete Metab. 1994; 20:99-107.
35. Neuman JC, Truchan NA, Joseph JW, Kimple ME. A method for mouse pancreatic islet isolation and intracellular cAMP determination. J Vis Exp. 2014; :e50374.
36. Do OH, Low JT, Thorn P. Lepr(db) mouse model of type 2 diabetes: pancreatic islet isolation and live-cell 2-photon imaging of intact islets. J Vis Exp. 2015; :e52632.
37. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005; 33:e179.
38. Schmittgen TD, Jiang J, Liu Q, Yang L. A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Res. 2004; 32:e43.